Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.

Yeva SahakyanAysegul ErmanNaeem BhojaniBilal ChughtaiKevin C ZornBeate SanderDean S Elterman

Published in: Prostate cancer and prostatic diseases (2022)

WVTT is an effective and cost-saving procedure, and may be an appropriate first-line alternative to pharmacotherapy for moderate-to-severe BPH patients who seek faster improvement and no lifelong commitment to daily medications.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
minimally invasive
high intensity
early onset
smoking cessation
physical activity
drug induced
cell fate